ClinicalTrials.Veeva

Menu

Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

A

Aversi Clinic

Status

Unknown

Conditions

Patient Participation

Treatments

Drug: perindopril-bisoprolol

Study type

Observational

Funder types

Other

Identifiers

NCT04484688
Prestilol

Details and patient eligibility

About

The study aims to evaluate the effectiveness and safety of oral fixed-dose combination of bisoprolol/perindopril in patients with permanent atrial fibrillation

Enrollment

50 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:permanent atrial fibrillation with normal EF -

Exclusion Criteria:AF with decreased EF

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems